The short answer
Vitamin B3 covers two molecules with different risk profiles. Nicotinamide, the form used in most supplements, is well tolerated at nutritional doses. Nicotinic acid causes flushing at just a few dozen milligrams, and at high doses it can damage the liver without protecting the heart.
Most people do not need a B3 supplement. The only use that has stood up to a rigorous trial is nicotinamide at 1 g per day, in people who have already had skin cancers, under medical supervision.
The real trap is confusing the two forms. In 2023, around ten supplements were recalled in France because a supplier had delivered nicotinic acid instead of nicotinamide.
One vitamin, two molecules
In the body, both forms of vitamin B3 are used to make NAD, a molecule essential to cellular energy production. It is the same NAD being marketed through supplements containing nicotinamide riboside · FR and NMN · FR, two other precursors.
When it comes to safety, however, they are worlds apart. The limits set by Europe in 2002, still in force according to the EFSA summary updated in 2025, are as follows:
- nicotinic acid: 10 mg per day in adults, a limit calculated on the basis of flushing
- nicotinamide: 900 mg per day, or 90 times as much
In France, the ministerial order of May 9, 2006 caps supplements at 8 mg of nicotinic acid and 54 mg of nicotinamide per day. A 2025 ministerial response specifies that these doses have never been changed, even though the authorities tolerated other doses through guidelines until 2019.
Requirements are modest. ANSES estimates them at around 14 mg per day for a moderately active young woman and 17 mg for a moderately active young man. The value shown on European labels is 16 mg. A varied diet covers these needs, especially since the body also makes B3 from tryptophan, an amino acid found in proteins.
One labeling detail complicates everything: the nutrition panel says “niacin” or “vitamin B3” regardless of the form. Only the ingredients list tells you which one is in the capsule.
Flushing: dramatic, rarely serious
Flushing is the hallmark of nicotinic acid. The skin on the face, neck and chest turns red, feels hot and tingles, sometimes enough to seem like an allergic reaction.
The mechanism is known. Nicotinic acid activates a receptor, GPR109A, on immune cells in the skin, which then release prostaglandins, messengers that widen blood vessels. Mice lacking this receptor no longer flush. According to a 2009 review, flushing starts soon after a dose, lasts about an hour and affects almost all patients treated with the immediate-release form at medicinal doses. Tolerance can develop in about a week.
The thresholds are low. The European scientific committee reported occasional flushing at doses as low as 30 mg per day. A single 50 mg dose causes it in 5% of people, and a 100 mg dose in half, according to the EFSA compilation of safety limits.
Nicotinamide, by contrast, does not cause flushing. Hence a practical rule: if a “skin” or “hair” supplement makes you feel hot within half an hour, it probably contains nicotinic acid. It is also found in some pre-workouts · FR.
Cholesterol: a drug that failed its trials
At doses of around a gram per day, nicotinic acid improves almost every number on a lipid panel. It lowers LDL and triglycerides, and raises HDL, the “good cholesterol.” For decades, it was used as a cholesterol drug.
Then came the large trials:
- AIM-HIGH, in 2011: 3,414 patients already taking a statin. HDL rose from 35 to 42 mg/dL, but the trial was stopped for lack of efficacy, with cardiovascular events in 16.4% of patients on niacin versus 16.2% on placebo
- HPS2-THRIVE, in 2014: 25,673 patients followed for nearly 4 years. No reduction in major vascular events, 13.2% versus 13.7%, but more serious adverse effects: poorly controlled diabetes, new diabetes diagnoses, infections, bleeding
- the 2017 Cochrane review: 23 trials, 39,195 participants. No reduction in mortality or strokes, an uncertain effect on heart attacks, and twice as many discontinuations due to adverse effects
HDL went up. Heart attacks did not go down. It is the classic example of a biomarker improving without the patient benefiting.
The European Medicines Agency reached its conclusion in 2013: the benefits of Tredaptive, which combined nicotinic acid with an anti-flushing agent, no longer outweighed the risks, and it was withdrawn from the market. Niacin also lowers lipoprotein(a) · FR, again without any demonstrated benefit. For LDL, the proven approaches · FR lie elsewhere.
The liver: the form that avoids flushing is the most toxic
To avoid flushing, the industry developed sustained-release forms. They cause less flushing and more liver damage.
In 1994, a trial published in JAMA compared the two forms in 46 patients, gradually increasing doses to 3 g per day. Liver injury developed in 12 of 23 patients taking the sustained-release form, and in none taking the immediate-release form. The authors concluded that use of the sustained-release form should be restricted.
The US database LiverTox classifies high-dose niacin as a well-established cause of liver injury. Above 500 mg per day, up to 20% of patients develop elevated transaminases, the liver enzymes. Severe cases, including fatal liver failure or the need for a transplant, mainly involve high-dose sustained-release forms, often after an abrupt switch from the immediate-release form.
This danger does not come from a supplement containing 15 mg. It comes from capsules containing several hundred milligrams, sold over the counter in the United States, and from the idea that a vitamin cannot do any harm. The roundup of supplements that genuinely put the liver at risk · FR gives other examples.
4PY: a worrying lead, not proof
In 2024, a Cleveland Clinic team published a widely circulated finding in Nature Medicine. When the body receives more B3 than it uses, it eliminates it as waste products, including 4PY.
Across three cohorts totaling more than 4,000 patients, a high 4PY level was associated with an almost twofold risk of heart attack, stroke or death at 3 years. In mice, 4PY triggered inflammation in blood vessel walls.
The authors themselves list the limitations: a single measurement, patients already at high risk, no data on their diet, and a genetic analysis that does not confirm a cause-and-effect relationship. They also note that nicotinamide riboside and NMN raise 4PY. It is a serious hypothesis, not a reason to panic, but it weakens the case for “more is better.”
Nicotinamide: the only use that stood up to a trial
Nicotinamide has a genuine potential indication under investigation: preventing non-melanoma skin cancers:
- the 2015 trial: 386 patients who had had at least two of these cancers in five years took 500 mg twice a day for one year. New cancers fell by 23%, and the effect disappeared after stopping
- the 2023 trial in organ transplant recipients: 158 patients, no effect, 207 cancers versus 210
- a 2025 study in US veterans: 12,287 people exposed, a risk 14% lower, and 54% lower when treatment began after a first cancer. This was an observational study in older men, almost all of whom were white
This dose of 1 g per day exceeds the general safety limit of 900 mg. It is a preventive treatment to discuss with a dermatologist, not a “beauty” vitamin to take on your own.
12 supplements recalled over the wrong form
The dietary supplement recall tracker lists 12 recalls linked to vitamin B3 across 8 brands. Ten of them fall between June 1 and August 7, 2023, and tell the same story: nicotinic acid was used instead of nicotinamide.
The first notice explains that the manufacturer is acting “following the supplier’s recall.” I found no public source explaining the raw material error. The affected products vary: hair, nail and skin formulas, where nicotinamide is a common ingredient, multivitamins, and formulas for hearing or nervous system balance.
The doses involved remain low. One notice cites 15 mg of nicotinic acid per capsule and per day, nearly twice the French cap of 8 mg, but below the threshold at which the European committee reported flushing. The actual risk is therefore limited: these recalls protect a safety margin; they do not signal poisoning.
In 2024, two other recalls involved excessively high-dose formulas, without any substitution. One exceeded the limit when more than one dose was taken per day. The other, a B-vitamin complex, provided 59 mg of nicotinic acid per day, nearly six times the safety limit. At this dose, some consumers may experience flushing.
The lesson goes beyond these batches. A multivitamin, a hair · FR formula and a pre-workout can each contain B3. This is the Pill Cupboard, the buildup of supplements taken without knowing which one does what: taken together, they add up to doses nobody has calculated.
The urine test myth
A persistent rumor claims that niacin can help you pass a urine drug test. It has landed people in intensive care.
Emergency physicians have published several case series:
- 4 patients in 2007, including two with liver injury, acidosis and sharp swings in blood glucose
- an adult in 2011, who had swallowed around 22.5 g of sustained-release niacin in 48 hours: renal failure, red blood cell destruction, clotting disorders, dialysis and ventilation
The authors of that last case are clear: there is no evidence that niacin interferes with a test. It just gives the emergency department more problems to deal with.
Who is actually deficient in B3?
Severe B3 deficiency is called pellagra. The World Health Organization summarizes it as dermatitis, diarrhea and dementia, while pointing out that the phrase is misleading: diarrhea is sometimes absent, dementia is rare, and depression is common.
Since the late 1980s, the WHO has mainly observed it in refugees and displaced people fed untreated corn. Elsewhere, it cites chronic alcoholism, malnutrition in isolated older people, certain digestive diseases that impair absorption, including Crohn’s disease, and some medicines, including isoniazid for tuberculosis. In these situations, a doctor must perform laboratory testing and provide treatment.
If you take it
If you take a supplement containing B3, a few rules are enough:
- check the form in the ingredients list: nicotinamide rather than nicotinic acid
- add up all your products, including multivitamins, beauty formulas and pre-workouts
- stay below the caps set by the 2006 ministerial order: 54 mg of nicotinamide or 8 mg of nicotinic acid per day
- avoid sustained-release niacin capsules bought from foreign websites
- stop taking a product that makes you flush and check its label
When to seek medical advice
Some situations require medical advice:
- call emergency services if you develop facial swelling, difficulty breathing or feel unwell after taking a dose
- call a poison control center after taking several grams, even without symptoms
- stop and seek medical advice if you develop jaundice, dark urine, nausea or persistent abdominal pain
- tell your doctor if you take a statin and develop muscle pain
- seek advice before taking any form of nicotinic acid if you have diabetes, gout, an ulcer or liver disease, and before taking high-dose nicotinamide during pregnancy, due to a lack of data





